INDUSTRY EXPERT ARTICLES

Jim Pearson advises October 29th is World Stroke Day (WSD) — an important day for the global stroke community to take action, educate, and focus on prevention. It is also a chance to deeply reflect on how we can continue to serve people who will suffer strokes in the future. For us leaders in the life sciences, WSD is a powerful reminder to ask ourselves how we can continue to innovate in order to decrease the lives lost and improve both clinical and economic outcomes. Over the past decade, we have built a company and team at NICO Corporation dedicated to bringing forth new innovations and, more importantly, scientific evidence in the deadliest type of stroke — hemorrhagic stroke. Read to learn more.

With cold and flu season approaching, more sick patients will be in hospitals in the coming months. Mr. Rizkallah discusses several challenges hospitals will face during this cold and flu season and how Honeywell’s real-time health monitoring system can improve patient outcomes. Read on.

More than a year ago, the U.S. healthcare system marked a turning point with the passage of the No Surprises Act (NSA). Signed into federal law after extensive negotiation between health plan insurers and providers, the NSA took full effect at the start of 2022 to protect the rights of patients and health plan participants from receiving excessive balance bills for certain emergency services and from out-of-network providers at in-network facilities.

Collecting patient-reported outcome (PRO) data is an integral function of clinical research, providing the patient perspective that enriches the evaluation of treatment effectiveness. Historically, patient-reported outcomes measurement (PROM) was performed predominantly with paper-based assessments. However, over the past two decades, there has been a notable paradigm shift towards the electronic collection of data.

Cancer care continues to be one of the key cost drivers contributing to the $3.5 trillion healthcare costs in the United States, but minimally invasive treatments like Cryoablation Therapy may hold the promise of significantly reducing oncology related costs, while improving patient outcomes. It has the potential of reducing months of recovery time to only a few minutes, and the scope of cryoablation expands exponentially especially when utilized in concert with personalized precision medicine. Read on.